NeuroMetrix, Inc. is an innovative medical device company that develops and markets home use and point-of-care devices, associated consumables, and support software for the treatment and management of diabetes and its complications. It is focused on the diagnosis and treatment of the neurological complications of diabetes. The company's products typically consist of a medical device and consumable biosensors. It currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy. NeuroMetrix was founded by Shai N. Gozani in June 1996 and is headquartered in Waltham, MA.